The success of pleurodesis depends on many factors. Failure of the procedure may be due to increased tumor burden, which causes a decrease in the mesothelial cells and, therefore, an inadequate inflammatory response.

Systemic inflammation and acute respiratory distress syndrome (ARDS) have been reported in patients receiving talc.

Some studies report systemic activation of the coagulation cascade, which leads to the formation of a pulmonary embolism in some patients.

Patients can develop a fever after pleurodesis; this is due to the inflammatory response of the body. Patients can also have an anaphylactic reaction to any of the chemical sclerosing agent. Pleural infection can occur if aseptic techniques are not followed.

In the case of surgical pleurodesis, there can be complications of general anesthesia, wound infection, atelectasis, etc.